{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:01:37Z","timestamp":1792587697621,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clnu.2025.07.029","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T16:59:39Z","timestamp":1754413179000},"page":"313-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Early nutritional and inflammation assessment predicts prognosis in patients with cancer across tumor origin and metastatic status"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8818-3383","authenticated-orcid":false,"given":"Juliette","family":"Renard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixtine","family":"De Percin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Arrondeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Thomas-Schoemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela Tiako","family":"Meyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mentine","family":"Villeminey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascaline","family":"Boudou-Rouquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Goldwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2731-6462","authenticated-orcid":false,"given":"Guillaume","family":"Beinse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2025.07.029_bib1","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.3390\/nu15143283","article-title":"The Prevalence and Impact of Nutritional Risk and Malnutrition in Gastrointestinal Surgical Oncology Patients: A Prospective, Observational, Multicenter, and Exploratory Study","volume":"15","author":"Dur\u00e1n Poveda","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2025.07.029_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.clnu.2025.07.029_bib3","first-page":"429","article-title":"Prevalence of hospital malnutrition in cancer patients: a sub-analysis of the PREDyCES\u00ae study","volume":"24","author":"Planas","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clnu.2025.07.029_bib4","doi-asserted-by":"crossref","first-page":"79884","DOI":"10.18632\/oncotarget.20168","article-title":"Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study","volume":"8","author":"Muscaritoli","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clnu.2025.07.029_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.clnu.2025.07.029_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1634\/theoncologist.2017-0255","article-title":"Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced Cancer","volume":"23","author":"Nipp","year":"2018","journal-title":"The Oncologist"},{"key":"10.1016\/j.clnu.2025.07.029_bib7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/cam4.621","article-title":"Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens","volume":"5","author":"Ali","year":"2016","journal-title":"Cancer Medicine"},{"key":"10.1016\/j.clnu.2025.07.029_bib8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/bjc.2016.431","article-title":"The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma","volume":"116","author":"Daly","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clnu.2025.07.029_bib9","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.clnu.2016.03.010","article-title":"Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer","volume":"35","author":"Sj\u00f8blom","year":"2016","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.clnu.2025.07.029_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/COC.0000000000000061","article-title":"Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With Sunitinib","volume":"40","author":"Cushen","year":"2017","journal-title":"American Journal of Clinical Oncology"},{"key":"10.1016\/j.clnu.2025.07.029_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139749","article-title":"Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index","volume":"10","author":"Choi","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clnu.2025.07.029_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jgo.2013.04.001","article-title":"Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy","volume":"4","author":"Aaldriks","year":"2013","journal-title":"Journal of Geriatric Oncology"},{"key":"10.1016\/j.clnu.2025.07.029_bib13","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1200\/JCO.2010.31.0664","article-title":"Comprehensive Geriatric Assessment in the Decision-Making Process in Elderly Patients With Cancer: ELCAPA Study","volume":"29","author":"Caillet","year":"2011","journal-title":"JCO"},{"key":"10.1016\/j.clnu.2025.07.029_bib14","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.26646","article-title":"Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score","volume":"118","author":"Extermann","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clnu.2025.07.029_bib15","first-page":"773","article-title":"The early discontinuation of palliative chemotherapy in older patients with cancer","volume":"22","author":"Kim","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clnu.2025.07.029_bib16","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1245\/s10434-023-13840-6","article-title":"Changes in Sarcopenia Status Predict Survival Among Patients with Resectable Esophageal Cancer","volume":"30","author":"Jogiat","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clnu.2025.07.029_bib17","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11605-008-0505-z","article-title":"Cachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer","volume":"12","author":"Bachmann","year":"2008","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1016\/j.clnu.2025.07.029_bib18","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.clnu.2025.07.029_bib19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jcsm.12307","article-title":"Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer","volume":"9","author":"Kays","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2025.07.029_bib20","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1200\/JCO.20.01670","article-title":"Management of Cancer Cachexia: ASCO Guideline\u2014Time to Address the Elephant in the Room","volume":"38","author":"Huillard","year":"2020","journal-title":"JCO"},{"key":"10.1016\/j.clnu.2025.07.029_bib21","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMe2411334","article-title":"Cancer Cachexia and the Brain Stem","volume":"391","author":"Baracos","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clnu.2025.07.029_bib22","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3390\/ijms21072321","article-title":"Cancer Cachexia and Related Metabolic Dysfunction","volume":"21","author":"Fonseca","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.clnu.2025.07.029_bib23","first-page":"223","article-title":"Systemic inflammation, nutritional status and survival in patients with cancer","volume":"12","author":"McMillan","year":"2009","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1016\/j.clnu.2025.07.029_bib24","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/annonc\/mdx271","article-title":"Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy","volume":"28","author":"Bozzetti","year":"2017","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.clnu.2025.07.029_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/0148607113502674","article-title":"Prevalence of Malnutrition and Current Use of Nutrition Support in Patients With Cancer","volume":"38","author":"H\u00e9buterne","year":"2014","journal-title":"J Parenter Enteral Nutr"},{"key":"10.1016\/j.clnu.2025.07.029_bib26","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/annonc\/mdw420","article-title":"Perspectives of health care professionals on cancer cachexia: results from three global surveys","volume":"27","author":"Muscaritoli","year":"2016","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.clnu.2025.07.029_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919899852","article-title":"Unmet needs in clinical nutrition in oncology: a multinational analysis of real-world evidence","volume":"12","author":"Caccialanza","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.clnu.2025.07.029_bib28","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.3390\/cancers15123206","article-title":"The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study","volume":"15","author":"Muscaritoli","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.clnu.2025.07.029_bib29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/bmjspcare-2017-001382","article-title":"A multidisciplinary rehabilitation programme for cancer cachexia improves quality of life","volume":"7","author":"Parmar","year":"2017","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.clnu.2025.07.029_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clnu.2025.07.029_bib31","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/jcsm.12756","article-title":"Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis","volume":"12","author":"Martin","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2025.07.029_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13539-012-0075-5","article-title":"Predicting survival in cancer patients: the role of cachexia and hormonal, nutritional and inflammatory markers","volume":"3","author":"Utech","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2025.07.029_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v025.i01","article-title":"FactoMineR: An R Package for Multivariate Analysis","volume":"25","author":"L\u00ea","year":"2008","journal-title":"Journal of Statistical Software"},{"key":"10.1016\/j.clnu.2025.07.029_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101195","article-title":"Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline","volume":"8","author":"Stone","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.clnu.2025.07.029_bib35","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Statistics in Medicine"},{"key":"10.1016\/j.clnu.2025.07.029_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s44276-024-00119-w","article-title":"The relationship between tumour necrosis, systemic inflammation, body composition and survival in patients with colon cancer","volume":"3","author":"Dolan","year":"2025","journal-title":"BJC Rep"},{"key":"10.1016\/j.clnu.2025.07.029_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.clnu.2025.07.029_bib38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-022-04847-2","article-title":"cGAS\u2013STING drives the IL-6-dependent survival of chromosomally instable cancers","volume":"607","author":"Hong","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.clnu.2025.07.029_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1477310","article-title":"Tocilizumab in combination with corticosteroids: potential for managing cancer cachexia with systemic hyperinflammation","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.clnu.2025.07.029_bib40","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/jcsm.13638","article-title":"Tocilizumab for Advanced Non-Small-Cell Lung Cancer With Concomitant Cachexia: An Observational Study","volume":"15","author":"Du","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2025.07.029_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MCO.0000000000001054","article-title":"Assessing cachexia in obesity: contradiction or perfectly possible?","volume":"27","author":"Baracos","year":"2024","journal-title":"Current Opinion in Clinical Nutrition & Metabolic Care"},{"key":"10.1016\/j.clnu.2025.07.029_bib42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.clnu.2025.07.029_bib43","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JOP.2016.016832","article-title":"Cancer Cachexia: Beyond Weight Loss","volume":"12","author":"Bruggeman","year":"2016","journal-title":"JOP"},{"key":"10.1016\/j.clnu.2025.07.029_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics.\u201d","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.clnu.2025.07.029_bib45","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of Cancer Cachexia: ASCO Guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"JCO"},{"key":"10.1016\/j.clnu.2025.07.029_bib46","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic Criteria for the Classification of Cancer-Associated Weight Loss","volume":"33","author":"Martin","year":"2015","journal-title":"JCO"},{"key":"10.1016\/j.clnu.2025.07.029_bib47","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1200\/JCO.23.01280","article-title":"Cancer Cachexia: ASCO Guideline Rapid Recommendation Update","volume":"41","author":"Roeland","year":"2023","journal-title":"JCO"},{"key":"10.1016\/j.clnu.2025.07.029_bib48","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the Treatment of Cancer Cachexia","volume":"391","author":"Groarke","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clnu.2025.07.029_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11912-016-0522-0","article-title":"Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)","volume":"18","author":"Crawford","year":"2016","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.clnu.2025.07.029_bib50","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1200\/JCO.2010.31.0664","article-title":"Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study","volume":"29","author":"Caillet","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clnu.2025.07.029_bib51","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jgo.2019.07.023","article-title":"Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: A survey of the prospective ELCAPA (ELderly CAncer PAtients) cohort","volume":"11","author":"Beinse","year":"2020","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.clnu.2025.07.029_bib52","series-title":"Enhancing the Diversity of Clinical Trial Populations \u2014 Eligibility Criteria, Enrollment Practices, and Trial Designs","year":"2020"},{"key":"10.1016\/j.clnu.2025.07.029_bib53","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomised controlled trials: \u201cTo whom do the results of this trial apply?","volume":"365","author":"Rothwell","year":"2005","journal-title":"The Lancet"},{"key":"10.1016\/j.clnu.2025.07.029_bib54","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jamaoncol.2018.5953","article-title":"Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation","volume":"5","author":"Unger","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clnu.2025.07.029_bib55","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/14796694.2024.2444874","article-title":"Prevalence of medical conditions or comorbidities influencing first-line therapy in unresectable hepatocellular carcinoma in the United States","volume":"21","author":"Schuler","year":"2025","journal-title":"Future Oncology"},{"key":"10.1016\/j.clnu.2025.07.029_bib56","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2003.08.010","article-title":"Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials","volume":"21","author":"Lewis","year":"2003","journal-title":"JCO"},{"key":"10.1016\/j.clnu.2025.07.029_bib57","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01635581.2014.894103","article-title":"Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer","volume":"66","author":"Barret","year":"2014","journal-title":"Nutrition and Cancer"},{"key":"10.1016\/j.clnu.2025.07.029_bib58","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","article-title":"Body Composition as an Independent Determinant of 5-Fluorouracil\u2013Based Chemotherapy Toxicity","volume":"13","author":"Prado","year":"2007","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.clnu.2025.07.029_bib60","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: Clinical Nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clinical Nutrition"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561425002055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561425002055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T02:26:14Z","timestamp":1756175174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561425002055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":59,"alternative-id":["S0261561425002055"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2025.07.029","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early nutritional and inflammation assessment predicts prognosis in patients with cancer across tumor origin and metastatic status","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2025.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}